Works matching DE "ATAZANAVIR"

Results: 442
    1
    2

    Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed study.

    Published in:
    European Journal of Clinical Pharmacology, 2025, v. 81, n. 5, p. 697, doi. 10.1007/s00228-025-03814-w
    By:
    • Saint-Lary, Laura;
    • Beau, Anna-Belle;
    • Sommet, Agnès;
    • Leroy, Valériane;
    • Loane, Maria;
    • Cavero-Carbonell, Clara;
    • Garne, Ester;
    • Hoareau, Jonathan;
    • Bielenska, Anna Latos;
    • Monier, Isabelle;
    • Nelen, Vera;
    • Neville, Amanda J.;
    • O'Mahony, Mary;
    • Perthus, Isabelle;
    • Pierini, Anna;
    • Rissmann, Anke;
    • Rouget, Florence;
    • Sichitiu, Joanna;
    • Tucker, David;
    • Dolk, Helen
    Publication type:
    Article
    3
    4

    Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1341, doi. 10.1007/s00228-021-03116-x
    By:
    • Usman, Sikiru Olatunji;
    • Oreagba, Ibrahim Adekunle;
    • Kadri, Michael Rotimi;
    • Adewumi, Ololade Oluwatosin;
    • Akinyede, Akinwumi;
    • Agbaje, Esther Oluwatoyin;
    • Abideen, Ganiyu;
    • Busari, AbdulWasiu Adeniyi;
    • Hassan, Olayinka Olaiwola;
    • Akinleye, Moshood Olusola;
    • Akanmu, Alani Sulaimon
    Publication type:
    Article
    5
    6
    7

    The Efficacy and Safety of Adding Chlorpromazine to Atazanavir/Ritonavir Regimen in the Treatment of Moderate COVID-19 Patients, a Randomized Double-blind Clinical Trial.

    Published in:
    Pharmaceutical & Biomedical Research, 2023, v. 9, n. 3, p. 211, doi. 10.32598/PBR.9.3.1084.1
    By:
    • Kame/aninejad, Sima;
    • Namvar, Hamid Reza;
    • Sohrabi, Masoumeh;
    • Darvishnia, David;
    • Ahangar, Nematollah;
    • A]ikhani, Ahmad;
    • Abbaspour, Hamideh;
    • Valadan, Reza;
    • Akbari, Zahra;
    • Akbari, Jafar;
    • Ghasemian, Roya;
    • Salehifar, Ebrahim
    Publication type:
    Article
    8
    9
    10
    11
    12

    Atazanavir nephrotoxicity.

    Published in:
    Clinical Kidney Journal, 2015, v. 8, n. 2, p. 137, doi. 10.1093/ckj/sfv015
    By:
    • Masaki Hara;
    • Akihiko Suganuma;
    • Naoki Yanagisawa;
    • Akifumi Imamura;
    • Tsunekazu Hishima;
    • Minoru Ando
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial.

    Published in:
    2021
    By:
    • Olagunju, Adeniyi;
    • Fowotade, Adeola;
    • Olagunoye, Ajibola;
    • Ojo, Temitope Olumuyiwa;
    • Adefuye, Bolanle Olufunlola;
    • Fagbamigbe, Adeniyi Francis;
    • Adebiyi, Akindele Olupelumi;
    • Olagunju, Omobolanle Ibitayo;
    • Ladipo, Olabode Taiwo;
    • Akinloye, Abdulafeez;
    • Adeagbo, Babatunde Ayodeji;
    • Onayade, Adedeji;
    • Bolaji, Oluseye Oladotun;
    • Happi, Christian;
    • Rannard, Steve;
    • Owen, Andrew
    Publication type:
    Letter
    23
    24
    25
    26
    27
    28
    29

    Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir.

    Published in:
    Infectious Diseases in Obstetrics & Gynecology, 2014, p. 1, doi. 10.1155/2014/961375
    By:
    • Samuel, Miriam;
    • Bradshaw, Daniel;
    • Perry, Melissa;
    • Chan, Sum Yee;
    • Dhairyawan, Rageshri;
    • Byrne, Laura;
    • Smith, Katherine;
    • Zhou, Judith;
    • Short, Charlotte Eve;
    • Naftalin, Claire;
    • Offodile, Ngozi;
    • Mandalia, Sundhiya;
    • Roedling, Sherie;
    • Shah, Rimi;
    • Brook, Gary;
    • Poulton, Mary;
    • Rodgers, Mette;
    • Sarner, Liat;
    • Noble, Heather;
    • Hay, Philip
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.

    Published in:
    2018
    By:
    • Fabbiani, Massimiliano;
    • Gagliardini, Roberta;
    • Ciccarelli, Nicoletta;
    • Roldan, Eugenia Quiros;
    • Latini, Alessandra;
    • d'Ettorre, Gabriella;
    • Antinori, Andrea;
    • Castagna, Antonella;
    • Orofino, Giancarlo;
    • Francisci, Daniela;
    • Chinello, Pierangelo;
    • Madeddu, Giordano;
    • Grima, Pierfrancesco;
    • Rusconi, Stefano;
    • Del Pin, Barbara;
    • Lombardi, Francesca;
    • D'Avino, Alessandro;
    • Focà, Emanuele;
    • Colafigli, Manuela;
    • Cauda, Roberto
    Publication type:
    journal article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

    Published in:
    2017
    By:
    • Di Giambenedetto, Simona;
    • Fabbiani, Massimiliano;
    • Roldan, Eugenia Quiros;
    • Latini, Alessandra;
    • D'Ettorre, Gabriella;
    • Antinori, Andrea;
    • Castagna, Antonella;
    • Orofino, Giancarlo;
    • Francisci, Daniela;
    • Chinello, Pierangelo;
    • Madeddu, Giordano;
    • Grima, Pierfrancesco;
    • Rusconi, Stefano;
    • Di Pietro, Massimo;
    • Mondi, Annalisa;
    • Ciccarelli, Nicoletta;
    • Borghetti, Alberto;
    • Focà, Emanuele;
    • Colafigli, Manuela;
    • De Luca, Andrea
    Publication type:
    journal article
    47
    48

    Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

    Published in:
    2017
    By:
    • Perez-Molina, J. A.;
    • Rubio, R.;
    • Rivero, A.;
    • Pasquau, J.;
    • Suárez-Lozano, I.;
    • Riera, M.;
    • Estébanez, M.;
    • Palacios, R.;
    • Sanz-Moreno, J.;
    • Troya, J.;
    • Mariño, A.;
    • Antela, A.;
    • Navarro, J.;
    • Esteban, H.;
    • Moreno, S.;
    • GeSIDA 7011 Study Group
    Publication type:
    journal article
    49
    50